FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.12  |  FHIR Version n/a  User: [n/a]

21609311000001104: Dapagliflozin 5mg tablets 28 tablet (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 12-Dec 2012. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
71625101000001117 Dapagliflozin 5mg tablets 28 tablet (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
71625201000001112 Dapagliflozin 5mg tablets 28 tablet en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module


6 descendants. Search Descendants:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Dapagliflozin 5mg tablets 28 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Dapagliflozin 5mg tablets 28 tablet Has VMP Dapagliflozin 5mg tablets true Inferred relationship Existential restriction modifier
Dapagliflozin 5mg tablets 28 tablet Has VMP Dapagliflozin 5mg tablets false Inferred relationship Existential restriction modifier
Dapagliflozin 5mg tablets 28 tablet Has specific active ingredient Dapagliflozin propanediol monohydrate true Inferred relationship Existential restriction modifier
Dapagliflozin 5mg tablets 28 tablet Is a Virtual medicinal product pack true Inferred relationship Existential restriction modifier
Dapagliflozin 5mg tablets 28 tablet Has VMP Dapagliflozin 5mg tablets false Inferred relationship Existential restriction modifier
Dapagliflozin 5mg tablets 28 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Dapagliflozin 5mg tablets 28 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Dapagliflozin 5mg tablets 28 tablet Has specific active ingredient Dapagliflozin false Inferred relationship Existential restriction modifier
Dapagliflozin 5mg tablets 28 tablet Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Dapagliflozin 5mg tablets 28 tablet Has specific active ingredient Dapagliflozin false Inferred relationship Existential restriction modifier
Dapagliflozin 5mg tablets 28 tablet Has VMP Product containing precisely dapagliflozin propanediol 5 milligram/1 each conventional release oral tablet false Inferred relationship Existential restriction modifier
Dapagliflozin 5mg tablets 28 tablet Has specific active ingredient Dapagliflozin propanediol monohydrate false Inferred relationship Existential restriction modifier
Dapagliflozin 5mg tablets 28 tablet Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Dapagliflozin false Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Forxiga 5mg tablets (Pharmaram Ltd) 28 tablet Is a True Dapagliflozin 5mg tablets 28 tablet Inferred relationship Existential restriction modifier
Forxiga 5mg tablets (DE Pharmaceuticals) 28 tablet Is a True Dapagliflozin 5mg tablets 28 tablet Inferred relationship Existential restriction modifier
Forxiga 5mg tablets (CST Pharma Ltd) 28 tablet Is a True Dapagliflozin 5mg tablets 28 tablet Inferred relationship Existential restriction modifier
Forxiga 5mg tablets (Ethigen Ltd) 28 tablet Is a True Dapagliflozin 5mg tablets 28 tablet Inferred relationship Existential restriction modifier
Forxiga 5mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) 28 tablet 2 x 14 tablets Is a True Dapagliflozin 5mg tablets 28 tablet Inferred relationship Existential restriction modifier
Forxiga 5mg tablets (Waymade Healthcare Plc) 28 tablet Is a True Dapagliflozin 5mg tablets 28 tablet Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start